The PrP genotype of sheep of the improved Valachian breed
Language English Country United States Media print
Document type Journal Article
PubMed
12800515
DOI
10.1007/bf02930968
Knihovny.cz E-resources
- MeSH
- Alleles MeSH
- Breeding MeSH
- Genetic Predisposition to Disease * MeSH
- Genotype MeSH
- Sheep Diseases genetics MeSH
- Sheep MeSH
- Polymerase Chain Reaction MeSH
- Polymorphism, Restriction Fragment Length MeSH
- Polymorphism, Genetic * MeSH
- Prions classification genetics MeSH
- Scrapie genetics MeSH
- Base Sequence MeSH
- Sequence Analysis, DNA MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Slovakia MeSH
- Names of Substances
- Prions MeSH
In a worldwide majority of sheep breeds an excessive susceptibility to scrapie associated with the PrP gene alleles coding for valine (V; at the 136 codon) and glutamine (Q; at the 171 codon) (e.g., VRQ/VRQ, VRQ/ARQ, or ARQ/ARQ) was demonstrated. Particularly the PrPVRQ allele is closely associated with the high-risk development of the disease; the PrPARQ allele can also fulfill this function but under certain limited conditions. Polymorphism in the PrP gene sequences (conclusively related to the increased susceptibility of sheep to scrapie) of improved Valachian sheep from two Slovak regions, Orava and Spis, was determined. Examination of 735 sheep showed that ARR/ARQ was the most frequent genotype (45.2%). High-risk genotypes were determined in 32.4% of sheep (ARQ/ARQ 19.3, ARR/VRQ 9.0, ARR/VRQ 3.5, VRQ/VRQ 0.3, ARR/VRR 0.3). Low-risk genotypes were found in 67.7% of sheep (ARR/ARQ 45.2, ARR/ARR 10.9, ARR/AHQ 5.7, ARQ/ARQ 4.9, AHQ/AHQ 0.7, ARR/AHR 0.3). Despite the geographically distant flocks of improved Valachian sheep investigated no difference in the occurrence of individual PrP genotypes was observed.
See more in PubMed
Eur J Epidemiol. 1991 Sep;7(5):520-3 PubMed
J Gen Virol. 1999 Sep;80 ( Pt 9):2527-34 PubMed
J Infect Dis. 1998 Oct;178(4):949-53 PubMed
APMIS. 2002 Jan;110(1):33-43 PubMed
Arch Virol. 1999;144(3):431-45 PubMed
Proc Natl Acad Sci U S A. 1997 May 13;94(10):4931-6 PubMed
J Comp Pathol. 2002 Jan;126(1):17-29 PubMed
J Gen Virol. 1993 Jun;74 ( Pt 6):1025-31 PubMed
Arch Virol. 1999;144(4):829-34 PubMed
Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13363-83 PubMed
EMBO J. 1985 Sep;4(9):2309-12 PubMed
J Gen Virol. 1994 May;75 ( Pt 5):989-95 PubMed
Vet Rec. 1998 Jun 6;142(23):623-5 PubMed
J Gen Virol. 1991 Oct;72 ( Pt 10):2411-7 PubMed
Genes Dev. 1994 Apr 15;8(8):959-69 PubMed
Folia Microbiol (Praha). 2000;45(6):475-83 PubMed
Vet Rec. 2000 Mar 18;146(12):335-8 PubMed
J Gen Virol. 1996 Oct;77 ( Pt 10):2669-73 PubMed
Nature. 1997 Mar 13;386(6621):137 PubMed
J Gen Virol. 1995 Aug;76 ( Pt 8):2097-101 PubMed
J Gen Virol. 1999 Apr;80 ( Pt 4):1073-7 PubMed
Ciba Found Symp. 1988;135:63-83 PubMed
Mamm Genome. 1993;4(8):463-4 PubMed
Arch Virol. 2001 Oct;146(10):2029-37 PubMed
Science. 1982 Apr 9;216(4542):136-44 PubMed
J Gen Virol. 1998 Aug;79 ( Pt 8):2079-82 PubMed
J Gen Virol. 1995 Oct;76 ( Pt 10):2577-81 PubMed
J Gen Virol. 1995 Mar;76 ( Pt 3):509-17 PubMed